 |
Interleukin-1 receptor antagonist, human recombinant |
|---|---|
| Trade Name | Antril |
| Orphan Indication | Juvenile rheumatoid arthritis |
| USA Market Approval | USA |
| USA Designation Date | 1991-09-23 00:00:00 |
| Sponsor | Swedish Orphan Biovitrum AB (publ) (SOBI);SE-112 76;Stockholm |
